G protein coupled receptors

### **G Protein-Coupled Receptors (GPCRs): A Comprehensive Overview**

#### **Introduction**

G Protein-Coupled Receptors (GPCRs) are a vast and highly versatile family of membrane proteins responsible for transmitting signals from the extracellular environment to the interior of cells. They are involved in a myriad of physiological processes, including sensory perception (vision, taste, smell), hormone regulation, neurotransmission, and immune responses. GPCRs are particularly significant in the gastrointestinal (GI) system, where they regulate digestion, absorption, motility, secretion, nutrient sensing, and immune function.

GPCRs are the targets for approximately 30-40% of all currently available drugs, making them one of the most important receptor families in pharmacology and medicine.

---

#### **Structure of GPCRs**

GPCRs share a conserved structural design characterized by:

1. **Seven Transmembrane (7TM) Helices**:

• These hydrophobic α-helices span the plasma membrane, forming the receptor's core structure.
• The arrangement creates a ligand-binding pocket on the extracellular side.

2. **Extracellular Domain**:

• This domain often serves as the binding site for ligands such as hormones, neurotransmitters, or sensory stimuli (e.g., photons, odorants).

3. **Intracellular Domain**:

• The cytosolic loops and tail interact with G proteins, initiating intracellular signaling cascades.

4. **Conserved Features**:

• Disulfide bonds stabilize the extracellular loops.
• Phosphorylation sites on the cytosolic domains regulate receptor activity through mechanisms like desensitization.

---

#### **Mechanism of GPCR Action**

GPCRs mediate signal transduction through the following steps:

1. **Ligand Binding**:

• A specific ligand binds to the extracellular domain of the GPCR, inducing activation.

2. **Conformational Change**:

• Ligand binding triggers a conformational change in the receptor, which is transmitted to the associated G protein.

3. **G Protein Activation**:

• G proteins are heterotrimeric (composed of α, β, and γ subunits) and exist in an inactive state bound to GDP.
• Upon GPCR activation, GDP is replaced by GTP on the α-subunit, leading to dissociation of the G protein into:
• **Active α-subunit (GTP-bound)**.
• **βγ dimer**.

4. **Effector Activation**:

• The activated α-subunit or βγ dimer interacts with downstream effectors (e.g., enzymes or ion channels), producing second messengers such as:
• **Cyclic AMP (cAMP)**: Activates protein kinase A (PKA).
• **Inositol Triphosphate (IP3)**: Mobilizes calcium from intracellular stores.
• **Diacylglycerol (DAG)**: Activates protein kinase C (PKC).

5. **Signal Termination**:

• The intrinsic GTPase activity of the α-subunit hydrolyzes GTP back to GDP, returning the G protein to its inactive state.

---

#### **Classification of GPCRs**

GPCRs are classified into distinct families based on their structural and functional characteristics:

1. **Class A (Rhodopsin-like)**:

• The largest and most common class.
• Includes receptors for small molecules (e.g., dopamine, serotonin) and peptides (e.g., somatostatin).
• Predominantly expressed in the GI tract.

2. **Class B (Secretin-like)**:

• Includes receptors for larger peptide hormones such as glucagon and vasoactive intestinal peptide (VIP).

3. **Class C (Metabotropic Glutamate-like)**:

• Includes receptors for neurotransmitters like glutamate and calcium-sensing receptors.

4. **Other Classes**:

• **Class F (Frizzled/Taste receptors)**: Involved in Wnt signaling and taste perception.
• **Adhesion GPCRs**: Play roles in cell adhesion and signaling.

---

#### **Role of GPCRs in the Gastrointestinal System**

GPCRs are integral to maintaining GI homeostasis and regulating various functions:

1. **Motility**:

• GPCRs like muscarinic receptors (M3) and serotonin receptors (5-HT4) regulate smooth muscle contraction and peristalsis.

2. **Secretion**:

• GPCRs mediate the secretion of digestive enzymes, bile acids, and gastric acid. For example:
• **Secretin receptors** stimulate bicarbonate secretion.
• **Gastrin receptors** promote gastric acid production.

3. **Nutrient Sensing**:

• GPCRs such as TGR5 (bile acid receptor) sense bile acids and regulate energy metabolism.

4. **Hormonal Regulation**:

• GPCRs mediate the effects of GI hormones like cholecystokinin (CCK), which regulates satiety and enzyme secretion.

5. **Immune Function**:

• Chemokine receptors (a subset of GPCRs) are involved in immune surveillance and inflammation within the gut.

---

#### **Clinical Relevance of GPCRs**

GPCRs are implicated in numerous diseases, particularly in the GI system, and are major targets for drug development.

1. **Diseases Associated with GPCR Dysregulation**:

• **Irritable Bowel Syndrome (IBS)**:
• Dysregulation of serotonin receptors (e.g., 5-HT3, 5-HT4) contributes to altered motility and visceral hypersensitivity.
• **Chronic Diarrhea**:
• Overactivation of GPCRs like guanylyl cyclase C (GC-C) by bacterial enterotoxins leads to excessive secretion.
• **Gastroesophageal Reflux Disease (GERD)**:
• GPCRs regulating smooth muscle tone in the lower esophageal sphincter are implicated.

2. **GPCRs as Drug Targets**:

• GPCR-targeted drugs are used to treat a wide range of conditions:
• **Ondansetron**: A 5-HT3 receptor antagonist used for chemotherapy-induced nausea.
• **Proton Pump Inhibitors (PPIs)**: Indirectly modulate GPCR pathways to reduce gastric acid secretion.
• **GLP-1 Receptor Agonists**: Used in diabetes and obesity management.
• **Antihistamines**: Target histamine GPCRs to alleviate allergies and acid reflux.

---

#### **Research and Future Directions**

GPCRs continue to be a focal point in biomedical research due to their therapeutic potential. Current areas of exploration include:

1. **Biased Agonism**:

• Developing ligands that preferentially activate specific signaling pathways while avoiding others, reducing side effects.

2. **Structural Studies**:

• Advances in crystallography and cryo-electron microscopy have provided detailed insights into receptor-ligand interactions, aiding in rational drug design.

3. **GPCR Therapeutics**:

• Novel GPCR-targeted therapies for GI cancers, inflammatory bowel diseases (IBD), and metabolic disorders are being actively developed.

4. **Synthetic Biology**:

• Engineering GPCRs with tailored ligand specificity for therapeutic applications.

---

#### **Exam Tips**

• **Key Facts**:
• GPCRs have **seven transmembrane domains**.
• G proteins are **heterotrimeric** (α, β, γ subunits).
• Second messengers include **cAMP, IP3, DAG**.
• **Gs** stimulates adenylate cyclase; **Gi** inhibits it; **Gq** activates phospholipase C.

• **Mnemonic for GPCR Classes**: **"A Secret Metabolic Family"** (A = Class A, Secret = Class B, Metabolic = Class C, Family = Other Classes).

---

#### **Summary Box**

| **Key Points** | **Details** |

|--------------------------------------|-----------------------------------------------------------------------------|

| **Structure** | 7 transmembrane helices; extracellular ligand-binding, intracellular G-protein interaction. |

| **Mechanism** | Ligand → GPCR activation → G protein dissociation → Second messengers. |

| **Role in GI System** | Regulates motility, secretion, nutrient sensing, and immune function. |

| **Clinical Importance** | GPCRs targeted in IBS, GERD, diarrhea, GI cancers, and metabolic disorders. |

| **Exam Tip** | Mnemonic: "A Secret Metabolic Family" for GPCR classes. |

---

In summary, G Protein-Coupled Receptors are essential molecular switches that mediate diverse physiological processes. Their structural complexity, functional versatility, and clinical significance make them a cornerstone of molecular biology, pharmacology, and therapeutic innovation.